R33 CA122890/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2009	5
2010	4
2011	4
2012	4
2013	3
2021	0

1

Microarrays in glycoproteomics research.

Yue T, Haab BB. Yue T, et al. Clin Lab Med. 2009 Mar;29(1):15-29. doi: 10.1016/j.cll.2009.01.001. Clin Lab Med. 2009. PMID: 19389548 Free PMC article. Review.

2

Antibody-lectin sandwich arrays for biomarker and glycobiology studies.

Haab BB. Haab BB. Expert Rev Proteomics. 2010 Feb;7(1):9-11. doi: 10.1586/epr.09.102. Expert Rev Proteomics. 2010. PMID: 20121469 Free PMC article. No abstract available.

3

Using lectins in biomarker research: addressing the limitations of sensitivity and availability.

Haab BB. Haab BB. Proteomics Clin Appl. 2012 Aug;6(7-8):346-50. doi: 10.1002/prca.201200014. Proteomics Clin Appl. 2012. PMID: 22927350 Free PMC article. Review.

4

Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases.

Yue T, Partyka K, Maupin KA, Hurley M, Andrews P, Kaul K, Moser AJ, Zeh H, Brand RE, Haab BB. Yue T, et al. Proteomics. 2011 Sep;11(18):3665-74. doi: 10.1002/pmic.201000827. Epub 2011 Aug 2. Proteomics. 2011. PMID: 21751362 Free PMC article.

5

Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.

Yue T, Maupin KA, Fallon B, Li L, Partyka K, Anderson MA, Brenner DE, Kaul K, Zeh H, Moser AJ, Simeone DM, Feng Z, Brand RE, Haab BB. Yue T, et al. PLoS One. 2011;6(12):e29180. doi: 10.1371/journal.pone.0029180. Epub 2011 Dec 29. PLoS One. 2011. PMID: 22220206 Free PMC article.

6

Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation.

Partyka K, Maupin KA, Brand RE, Haab BB. Partyka K, et al. Proteomics. 2012 Jul;12(13):2212-20. doi: 10.1002/pmic.201100676. Proteomics. 2012. PMID: 22623153 Free PMC article.

7

Modulation of glycan detection on specific glycoproteins by lectin multimerization.

Cao Z, Partyka K, McDonald M, Brouhard E, Hincapie M, Brand RE, Hancock WS, Haab BB. Cao Z, et al. Anal Chem. 2013 Feb 5;85(3):1689-98. doi: 10.1021/ac302826a. Epub 2013 Jan 16. Anal Chem. 2013. PMID: 23286506 Free PMC article.

8

The Marker State Space (MSS) method for classifying clinical samples.

Fallon BP, Curnutte B, Maupin KA, Partyka K, Choi S, Brand RE, Langmead CJ, Tembe W, Haab BB. Fallon BP, et al. PLoS One. 2013 Jun 4;8(6):e65905. doi: 10.1371/journal.pone.0065905. Print 2013. PLoS One. 2013. PMID: 23750276 Free PMC article.

9

Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification.

Partyka K, McDonald M, Maupin KA, Brand R, Kwon R, Simeone DM, Allen P, Haab BB. Partyka K, et al. J Proteome Res. 2012 May 4;11(5):2904-11. doi: 10.1021/pr2012736. Epub 2012 Apr 4. J Proteome Res. 2012. PMID: 22439797 Free PMC article.

10

Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.

Wu YM, Nowack DD, Omenn GS, Haab BB. Wu YM, et al. J Proteome Res. 2009 Apr;8(4):1876-86. doi: 10.1021/pr8008379. J Proteome Res. 2009. PMID: 19714813 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results